Product Information
XARELTO 2.5 MG TABLET is a brand product labeled by Janssen Pharmaceuticals Inc., priced at $9.7776 per EA under NDC 50458057710. Its NADAC has been published 393 times since Dec 19, 2018.
The High Outlier badge above means this manufacturer's average price in the rivaroxaban market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
2.5 mg/1
Manufacturer
Janssen Pharmaceuticals Inc.NDC
50458057710
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RIVAROXABANApproval Type
New Drug (NDA)
FDA Application
NDA022406On Market Since
10/9/2018
Pharmacological Classes
Price Statistics
The NADAC for XARELTO 2.5 MG TABLET has been published 393 times since Dec 19, 2018, and over the history we have for it it has risen 46.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.7776 per EA |
|---|---|
| All-time high | $9.7866 (Jun 10, 2026) |
| All-time low | $6.6842 (Dec 19, 2018) |
| 52-week high | $9.7866 |
| 52-week low | $9.5585 |
| Median price | $8.2794 |
| Average price | $8.3712 |
| Largest weekly change | +6.9% (Jan 16, 2019) |
| Weeks tracked | 393 |
| Tracking since | Dec 19, 2018 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 92% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of XARELTO 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for XARELTO 2.5 MG TABLET, manufactured by Janssen Pharmaceuticals Inc., is $9.7776 per EA (NDC 50458057710), effective Jun 24, 2026.
How has the price of XARELTO 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for XARELTO 2.5 MG TABLET has risen 46.3%. It has been tracked across 393 weekly CMS publications since Dec 19, 2018.
What are the highest and lowest recorded NADAC prices for XARELTO 2.5 MG TABLET?
Since Dec 19, 2018, the NADAC for XARELTO 2.5 MG TABLET has ranged from a low of $6.6842 (Dec 19, 2018) to a high of $9.7866 (Jun 10, 2026), with a median of $8.2794 per EA.
Are there cheaper alternatives to XARELTO 2.5 MG TABLET?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, RIVAROXABAN 2.5 MG TABLET, is $0.7967 per EA — about 92% below XARELTO 2.5 MG TABLET.
Who manufactures XARELTO 2.5 MG TABLET?
XARELTO 2.5 MG TABLET (NDC 50458057710) is labeled by Janssen Pharmaceuticals Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification